Evolus

$9.60 0.00% ($0.00)

Get ready to invest

About Evolus

Evolus, Inc. is a medical aesthetics company. The Company is focused on providing physicians and aesthetic procedures and treatments. It also focuses on offering the self-pay aesthetic market and its product candidate, PrabotulinumtoxinA (DWP-450), is an injectable 900 kilodalton, or kDa, botulinum toxin type designed to address the needs of the large and growing facial aesthetics market. It offers physicians and patients a compelling value proposition with DWP-450. OnabotulinumtoxinA (BOTOX) is the neurotoxin approved 900 kDa botulinum toxin type A complex in the United States.

Popular Stocks	Price	Change
Nu Holdings NU	$4.705 10.71%	10.71%
AMC AMC	$24.1701 1.1%	1.1%
AMD AMD	$101.265 0.43%	0.43%
Invitae NVTA	$5.0801 5.4%	5.4%
Snap SNAP	$12.355 6.33%	6.33%
Bed Bath & Beyond BBBY	$16.185 24.98%	24.98%
Ford F	$16.365 1.14%	1.14%
Apple AAPL	$173.12 0.59%	0.59%
Tilray TLRY	$4.295 6.58%	6.58%
Ironsource Ltd IS	$4.44 10.72%	10.72%